Hormones, Weight Loss and Detoxification: Where Sulforaphane Fits

The word detoxification has become difficult to use without creating confusion.

On one side are juice cleanses, powders, foot baths and vaguely defined programs promising to pull unnamed toxins out of the body. On the other is the equally unhelpful response that detoxification is somehow a fictional concept invented by the wellness industry.

The human body detoxifies continuously. It could not function otherwise.

The liver changes the chemical structure of hormones, medications, alcohol and many environmental compounds. Enzymes make some substances less active, prepare others for elimination and sometimes create intermediate metabolites that must be processed further. The kidneys filter and excrete water-soluble compounds. Bile carries selected metabolites into the gastrointestinal tract. The intestine affects what is eliminated and what can be reabsorbed.

This is normal physiology, not a cleanse.

It is also why nutrition matters. These pathways require amino acids, vitamins, minerals and a functioning gastrointestinal system. A person living largely on ultra-processed food, drinking too much alcohol, eating little fiber and getting very few vegetables is not providing the same nutritional environment as someone eating a varied diet rich in whole foods.

That still does not mean we need to turn every hormone prescription or weight-loss program into an elaborate detoxification protocol.

What Detoxification Actually Means

The liver is not a filter that gradually fills with toxins until it needs to be cleaned. It is an active metabolic organ performing thousands of chemical reactions every day.

Some of the pathways commonly described as “phase I” and “phase II” metabolism are legitimate biochemical systems. Cytochrome P450 enzymes, for example, participate in the metabolism of drugs, steroid hormones and environmental chemicals. Conjugation reactions involving glucuronidation, sulfation and glutathione can make compounds easier to transport or eliminate.

These systems are interconnected with nutrition, genetics, medications, alcohol exposure, liver disease, kidney function, the intestinal tract and overall metabolic health.

This is the context in which we use the term detoxification at HormoneSynergy®. It does not mean forcing the body through a temporary cleanse. It means maintaining the physiologic systems that are already responsible for processing and eliminating compounds every day.

We have discussed this distinction in more detail in Detoxification Is Not Something You Buy in a Bottle and The Liver Is Not a Dirty Sponge.

What Happens to Hormones After They Are Used?

Hormones do not simply circulate forever.

Steroid hormones such as estrogen, progesterone and testosterone are metabolized through a series of enzymatic steps. Their metabolites may be biologically active, less active or inactive. Some are conjugated in the liver and eventually eliminated through urine or bile. Others can undergo additional metabolism in peripheral tissues.

This normal processing is sometimes described in wellness literature by saying that “used hormones become toxins.” We do not think that is an accurate way to explain the physiology.

Estrogen is not transformed into a generic toxin after it has delivered a signal. There are many estrogen metabolites, and their biological behavior differs. Some metabolic pathways have been investigated because certain reactive estrogen metabolites can participate in oxidative chemistry and DNA damage under experimental conditions. That is an important area of research. It does not justify describing hormone replacement therapy itself as creating a toxic waste problem.

The same caution is important when discussing progesterone, testosterone, thyroid hormone, insulin and GLP-1-based medications. These molecules do not share one common “detox pathway.” Their metabolism and elimination are different.

A patient using menopausal hormone therapy should be monitored because hormone therapy is medical treatment. Dose, route, symptoms, bleeding patterns, breast health, cardiovascular risk, bone health and other individual factors may matter. Routine medical monitoring should not be replaced by the assumption that every patient simply needs more detoxification.

The Gut Does Participate in Estrogen Metabolism

This is one area where an idea that was once discussed mostly in functional medicine has developed a more substantial scientific foundation.

Some estrogens are conjugated in the liver and secreted into bile. Once they reach the intestine, bacterial enzymes can deconjugate a portion of those metabolites. That can make estrogen available for reabsorption rather than elimination in stool.

The collection of microbial genes involved in estrogen metabolism is commonly referred to as the estrobolome.

Bacterial beta-glucuronidase activity is particularly interesting because glucuronidation is one of the mechanisms the body uses to prepare estrogen metabolites for elimination. Deconjugation in the intestinal tract creates an opportunity for some of that estrogen to re-enter circulation.

This is real biology. The unanswered question is how much we can currently manipulate it in an individual patient to improve meaningful clinical outcomes.

Research published through 2026 continues to find associations among the gut microbiome, microbial enzyme activity, estrogen exposure and hormone-related disease. Much of the human evidence remains associative. We do not yet have evidence showing that routinely testing intestinal beta-glucuronidase and treating the result reduces breast cancer, endometrial cancer or complications from menopausal hormone therapy.

There are nevertheless simple reasons to care about gastrointestinal function. Adequate dietary fiber, a varied plant-forward diet and normal bowel function are good ideas regardless of whether someone is taking estrogen. Constipation is not an ideal endpoint for compounds the body is trying to eliminate through stool.

Our broader approach to this subject is discussed in the HormoneSynergy® Gut Health, Microbiome and Longevity Medicine Guide.

Body Fat Can Store More Than Energy

Adipose tissue is metabolically active. It stores energy, produces signaling molecules, participates in sex-hormone metabolism and can also serve as a reservoir for certain fat-soluble environmental chemicals.

Persistent organic pollutants are the clearest example. Some polychlorinated biphenyls, organochlorine pesticides and related compounds are lipophilic and can remain in adipose tissue for long periods.

When someone loses a substantial amount of body fat, some of those stored compounds can move back into circulation.

This has been demonstrated in human studies. A review of weight-loss studies found that blood concentrations of many measured persistent organic pollutants increased as people lost significant amounts of weight. The effect was particularly apparent after large or rapid weight loss.

That finding is interesting, but it needs perspective.

The studies have not established that intentional weight loss becomes harmful because pollutants are mobilized from adipose tissue. The same review emphasized that there was very little evidence connecting the transient or sustained increase in circulating pollutant concentrations with meaningful clinical harm. The established health benefits of appropriate weight reduction continue to outweigh this theoretical concern.

We therefore would not discourage an overweight patient from losing visceral fat because some stored pollutants may temporarily increase in the circulation.

We would pay attention to nutrition while the patient is losing weight.

GLP-1 Medications Do Not Create a New Category of “Toxins”

This distinction has become more important with the widespread use of semaglutide, tirzepatide and related medications.

Patients can lose substantial amounts of body fat with GLP-1-based therapy. If persistent environmental chemicals are stored in that adipose tissue, fat loss can alter their distribution just as it can during bariatric surgery or substantial weight loss achieved through diet.

That does not mean the medication itself is causing a toxic release.

The relevant variable is loss of adipose tissue.

We have not seen evidence demonstrating that people taking GLP-1 medications require a specialized detoxification protocol to prevent disease. There is also no established evidence that adding such a protocol makes GLP-1 treatment safer or reduces cancer risk.

There are, however, very practical nutritional concerns during major weight loss.

Patients eating substantially less food may also eat less protein, fiber and micronutrient-dense food. Constipation is common with GLP-1 therapy. Lean mass can decline along with fat mass. Some patients become so focused on eating fewer calories that diet quality gets worse rather than better.

Those are problems worth addressing.

Our emphasis during medically supervised weight loss is therefore much less exotic: adequate protein, resistance training, preservation of muscle, hydration, fiber and bowel regularity, sufficient micronutrition, and monitoring body composition rather than simply watching the scale. See GLP-1s, Muscle Preservation, and the Future of Weight Loss in Longevity Medicine.

Where Glucoraphanin and Sulforaphane Fit

This is one of the nutritional interventions we think deserves to be taken seriously without being oversold.

Broccoli, broccoli sprouts, Brussels sprouts, cabbage, kale, cauliflower and other cruciferous vegetables contain glucosinolates. Glucoraphanin is one of them.

Glucoraphanin is a precursor. The enzyme myrosinase converts glucoraphanin into sulforaphane, an isothiocyanate that has been studied for several decades.

The best-established molecular target for sulforaphane is the KEAP1-NRF2 pathway. NRF2 helps regulate the expression of numerous genes involved in cellular defense, redox balance and enzymes involved in the metabolism of electrophiles and some environmental chemicals.

That mechanism has moved well beyond cell-culture experiments. Sulforaphane and glucoraphanin-rich broccoli preparations have been studied in numerous human trials.

One of the more interesting lines of research involves exposure to airborne pollutants. Human studies using broccoli sprout preparations have found increased urinary excretion of metabolites of compounds such as benzene and acrolein. A randomized crossover trial in smokers also demonstrated increased elimination of a benzene metabolite following a broccoli seed and sprout preparation.

This is legitimate evidence that manipulating these pathways can alter the handling of certain compounds in humans.

It is not evidence that sulforaphane removes every environmental toxin, nor does it establish that taking sulforaphane during hormone therapy or weight loss prevents cancer.

Why We Sometimes Use It

Ideally, nutrition begins with food.

In practice, many patients are not eating broccoli sprouts, broccoli, cabbage, kale or Brussels sprouts with any regularity. Some eat very few vegetables at all. That is one reason we may consider a glucoraphanin/sulforaphane product as part of a broader nutritional plan.

We are not trying to replace vegetables with a capsule. Cruciferous vegetables contain fiber, folate, vitamin C, potassium, carotenoids, other glucosinolates and many compounds that are not reproduced by an isolated supplement.

A standardized product can, however, provide a more consistent amount of glucoraphanin or sulforaphane-related activity than someone's occasional serving of broccoli.

Formulation matters.

Glucoraphanin by itself is not sulforaphane. Conversion depends on myrosinase from the plant preparation or, less predictably, microbial enzymes in the intestinal tract. Human research has repeatedly shown that the presence and activity of myrosinase can materially change sulforaphane bioavailability.

A randomized human study published in 2026 found that adding a defined source of myrosinase to a glucoraphanin-rich broccoli seed extract approximately doubled average sulforaphane bioavailability compared with glucoraphanin alone. This is one reason we pay attention to formulation rather than simply looking for the word “broccoli” on a supplement label.

Targeted Nutritional Support When It Makes Sense

We use supplements with the same perspective we bring to the rest of longevity medicine: in addition to, not as a substitute for, a healthy diet and lifestyle.

If someone rarely eats cruciferous vegetables, improving the diet remains the first recommendation. Broccoli, broccoli sprouts, cabbage, cauliflower, kale and Brussels sprouts provide far more than glucoraphanin alone. They also provide fiber, vitamins, minerals and other plant compounds that cannot be reproduced in a capsule.

There are times, however, when a more consistent or targeted intake makes sense. Depending on the individual, we may consider several different approaches.

Avmacol® Extra Strength is the most direct of these options when the goal is glucoraphanin and sulforaphane-related nutritional support.* It combines broccoli seed and sprout extract as a source of glucoraphanin with active myrosinase to support conversion to sulforaphane.* The Extra Strength formulation also includes beta-glucan and maitake mushroom for additional immune and cellular support.*

For patients in whom estrogen metabolism is part of the nutritional discussion, RetzlerRx® Estro Protect DIM combines diindolylmethane (DIM) with indole-3-carbinol (I3C), two compounds associated with cruciferous vegetables and commonly used to support normal estrogen-metabolism pathways.* It may be considered in women or men when targeted nutritional support for estrogen metabolism is appropriate.*

RetzlerRx® Breast Protect takes a broader approach. It combines DIM with Curcumin C3 Complex® and green tea extract, pairing estrogen-metabolism support with additional plant-derived antioxidant support.*

These formulas are not interchangeable, and using more products is not necessarily better. The choice depends on what we are trying to accomplish, what the patient already eats, other supplements and medications being used, and the larger clinical picture.

Most importantly, none of these products should be viewed as a substitute for eating well, exercising, maintaining a healthy body composition, limiting excessive alcohol, avoiding tobacco, sleeping adequately and obtaining appropriate medical screening. Nor should they be interpreted as cancer-prevention treatments. They are nutritional tools that may be added to those foundations when there is a reasonable purpose for doing so.

Sulforaphane Is Not a Cancer Treatment

Sulforaphane attracts considerable attention in cancer research, and for understandable reasons. It affects Nrf2 signaling, inflammatory pathways, cellular stress responses and a number of mechanisms being studied in carcinogenesis. Human clinical trials have examined it in prostate cancer, breast cancer and other settings.

The evidence is not strong enough to say that a sulforaphane supplement prevents cancer in an individual patient.

There is a considerable distance between demonstrating a cellular mechanism, changing a biomarker in a clinical trial and proving that an intervention reduces cancer incidence or mortality.

We can be interested in sulforaphane without turning promising nutritional science into a cancer-prevention claim.

What We Actually Pay Attention To

When a patient is using hormone therapy, losing a substantial amount of weight or simply trying to improve long-term metabolic health, we do not begin by assuming that he or she has a generalized detoxification problem.

We look at what is actually happening.

Is the diet adequate? Is protein intake sufficient? Are vegetables and fiber nearly absent? Is the patient constipated? Is alcohol intake high? Are liver enzymes abnormal? Is there fatty liver disease? Is kidney function normal? Are there medications that need to be considered? Is there a legitimate occupational or environmental exposure? Is rapid weight loss resulting in inadequate nutrition or excessive lean-mass loss?

Those questions are more useful than assigning every patient to the same cleanse.

There are circumstances in which testing for a specific toxicant makes sense. Known lead exposure is different from vaguely feeling “toxic.” Occupational mercury exposure is different from ordering a large environmental panel on every healthy person. Abnormal liver function deserves medical evaluation rather than a liver-cleanse supplement.

We may use nutritional compounds such as glucoraphanin/sulforaphane because the physiology and human evidence are reasonable and because many people do not obtain much of these compounds from their usual diet. That decision is part of nutrition, not proof that the patient is poisoned.

The Diet Still Comes First

The irony of modern detoxification culture is that it can make normal food seem almost too ordinary.

A diet containing cruciferous vegetables, other colorful plants, sufficient protein, legumes, nuts, seeds, healthy fats and adequate fiber does not sound nearly as sophisticated as a seven-day detoxification program. Yet it provides the raw materials the body uses every day.

The same applies to alcohol. Reducing excessive alcohol exposure is likely to matter more to liver health than adding another liver supplement while continuing to drink heavily.

Bowel regularity matters. Hydration matters. Sleep matters. Maintaining healthy body composition matters. Avoiding tobacco smoke matters. Reducing unnecessary occupational or environmental exposures when they are known matters.

Supplements can be useful additions to that foundation. They should not become a way to avoid it.

A More Useful Definition of Detoxification

We think detoxification is most useful when it is understood as ordinary human physiology that can be helped or hindered by the environment in which it operates.

Hormones have to be metabolized. The intestine does participate in estrogen recycling. Adipose tissue can store certain persistent environmental compounds. Substantial fat loss can mobilize some of them. Sulforaphane can activate well-characterized cellular defense pathways and has changed the excretion of selected environmental chemicals in human studies.

All of those statements can be true at the same time without concluding that every patient needs a detox program.

The medical question is narrower. Is there evidence of an actual problem? Is there a modifiable exposure? Is the patient eating well enough to provide the nutrients required for normal metabolism? Is bowel function adequate? Are the liver and kidneys healthy? Is there a reason to add a targeted nutritional intervention?

Sometimes the answer includes glucoraphanin or sulforaphane.

Sometimes the answer is simply more vegetables.

Usually the best approach is less dramatic than the word detox suggests.

Selected Evidence

Sulforaphane clinical research: A 2025 comprehensive review identified dozens of human clinical trials examining sulforaphane and broccoli-derived preparations, including research on KEAP1-NRF2 signaling and cellular defense pathways. PMID: 40988712.

Glucoraphanin, myrosinase and bioavailability: Human research has demonstrated that glucoraphanin requires enzymatic conversion to sulforaphane and that active myrosinase can substantially improve conversion. A randomized clinical study published in 2026 confirmed greater sulforaphane bioavailability when glucoraphanin was administered with a defined myrosinase source. PMID: 41692762.

Airborne pollutant metabolism: Human broccoli sprout intervention studies have demonstrated increased urinary excretion of metabolites of benzene, acrolein and selected other airborne compounds. PMID: 22045030; PMID: 35565256.

Persistent organic pollutants and weight loss: A review of 17 human studies found that concentrations of many persistent organic pollutants increased in blood following significant weight reduction, while emphasizing that evidence connecting this finding with adverse clinical outcomes remains limited and that the known benefits of weight loss outweigh the theoretical risk. PMID: 28051929.

The estrobolome: Contemporary reviews describe microbial beta-glucuronidase, sulfatase and related activity involved in enterohepatic estrogen recycling while noting that much of the human evidence connecting the estrobolome with cancer and other clinical outcomes remains associative. PMID: 42401355.

This article is for general educational purposes and is not intended to diagnose, treat, cure or prevent disease. Nutritional supplements are not appropriate for every patient and can interact with medical conditions and medications. Individual treatment decisions should be made with a qualified healthcare professional.

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.